Expression of CD44 isoforms in infiltrating lobular carcinoma of the breast

被引:34
作者
Berner, HS [1 ]
Nesland, JM [1 ]
机构
[1] Univ Oslo, Norwegian Radium Hosp, Dept Pathol, N-0310 Oslo, Norway
关键词
infiltrating lobular carcinoma; immunohistochemistry; CD44;
D O I
10.1023/A:1006417412046
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Expression of CD44 has been shown to correlate with the progression and prognosis of some malignant tumors. The aim of this study was to evaluate the expression of CD44 isoforms in infiltrating lobular carcinomas and analyse their potential as prognostic indicators. A panel of 39 tumors were examined for their expression of membranous and cytoplasmic CD44s, v3, v5, v6, v7 and v3-10 in the infiltrating cells, by immunohistochemical staining. The protein positive tumors showed membranous and/or cytoplasmic staining with all antibodies used except for CD44v7, which only displayed cytoplasmic staining. Cytoplasmic expression of CD44v3 (P = 0.014) and membranous expression of v6 (P = 0.039) were significantly associated with alveolar, classical/alveolar carcinomas and mucinous/alveolar carcinomas. Furthermore, in alveolar, classical/alveolar and mucinous/alveolar carcinomas, cytoplasmic staining of CD44v5 was correlated with lymph node negative patients (P = 0.048), whereas membranous v5 was correlated with lymph positive patients (P = 0.048). In classical, classical/trabecular and trabecular carcinomas expression of membranous CD44s was significantly correlated with lymph node status (P = 0.042).
引用
收藏
页码:23 / 29
页数:7
相关论文
共 50 条
  • [41] Different prognostic significance of CD24 and CD44 expression in breast cancer according to hormone receptor status
    Kim, Hee Jeong
    Kim, Mi-Jung
    Ahn, Sei Hyun
    Son, Byung Ho
    Kim, Sung Bae
    Ahn, Jin Hee
    Noh, Woo Chul
    Gong, Gyungyub
    BREAST, 2011, 20 (01) : 78 - 85
  • [42] CD44 expression during tumor progression of follicular lymphoma
    Higashi, Morihiro
    Sugaya, Yoshiki
    Soeta, Satoshi
    Yokota, Akira
    Ishii, Genichiro
    Harigaya, Kenichi
    ONCOLOGY REPORTS, 2009, 22 (05) : 1135 - 1140
  • [43] DIFFERENTIAL EXPRESSION OF CD44 IN MALIGNANT CUTANEOUS EPITHELIAL NEOPLASMS
    PRIETO, VG
    REED, JA
    MCNUTT, NS
    BOGDANY, JK
    LUGO, J
    SHEA, CR
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 1995, 17 (05) : 447 - 451
  • [44] Immunohistochemical expression of the CD44 variant 6 in colorectal adenocarcinoma
    Ishida, T
    SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY, 2000, 30 (01): : 28 - 32
  • [45] High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
    Si, Daolin
    Yin, Fei
    Peng, Jing
    Zhang, Guangying
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 769 - 775
  • [46] Expression of CD44 in premalignant and malignant Barrett's oesophagus
    Lagorce-Pages, C
    Paraf, F
    Dubois, S
    Belghiti, J
    Fléjou, JF
    HISTOPATHOLOGY, 1998, 32 (01) : 7 - 14
  • [47] Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma
    Böhm, JP
    Niskanen, LK
    Pirinen, RT
    Kiraly, K
    Kellokoski, JK
    Moisio, KI
    Eskelinen, MJ
    Tulla, HE
    Hollmen, S
    Alhava, EM
    Kosma, VM
    JOURNAL OF PATHOLOGY, 2000, 192 (03) : 321 - 327
  • [48] CLINICAL UTILITY OF MCM2 AND CD44 EXPRESSION IN CLEAR CELL RENAL CELL CARCINOMA
    Gayyed, Mariana F.
    Soliman, Medhat M.
    El-Hussieny, Maram
    POLISH JOURNAL OF PATHOLOGY, 2020, 71 (04) : 339 - 346
  • [49] Expression of androgen receptor, gross cystic disease fluid protein, and CD44 in salivary duct carcinoma
    Kapadia, SB
    Barnes, L
    MODERN PATHOLOGY, 1998, 11 (11) : 1033 - 1038
  • [50] Infiltrating lobular carcinoma - a comparison of diagnosis, management and outcome with infiltrating duct carcinoma
    Molland, JG
    Donnellan, M
    Janu, NC
    Carmalt, HL
    Kennedy, CW
    Gillett, DJ
    BREAST, 2004, 13 (05) : 389 - 396